Mile Brujic, OD, explores why it might be a good idea to expand the use of fluorescein staining when evaluating the ocular surface. Although fluorescein staining is often reserved for use in symptomatic patients, its use in patients with mild or no symptoms of ocular surface disease may reveal anomalies that are not detectable on clinical examination. Use of the dye as a routine diagnostic adjunct, Dr. Brujic says, may help reveal the cause of unexplained blurred vision, uncomfortable eyes, refractive shift, and corneal compromise, especially in patients with tear film irregularities.
